Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

EBR/BIOS stock hub

EBR/BIOS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

EBR/BIOSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.4M

Euronext Brussels

Market data

Price

Recent price action with selectable time range.

EBR/BIOSEBR/BIOS

—

Loading chart…

In the news

Latest news · EBR/BIOS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-101.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All EBR/BIOS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

146

Groups with data

Currency

EUR

Showing 146 of 146 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Belgium
Country code	BE
Employees	7
Employees Change	5%
Employees Change Percent	250
Enterprise value	EUR 24.5M
Exchange	Euronext Brussels
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Isin	BE0974280126
Last refreshed	2026-05-10
Market cap	EUR 1.4M
Price	EUR 0
Price currency	EUR
Rev Per Employee	-341,000x
Sector	Healthcare
Sic	2836
Symbol	ebr/BIOS
Website	https://www.biosenic.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-278.22%
EV Earnings	-6.12x
P/B ratio	-0.06x
P/S ratio	-0.6x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	EUR -2.4M
Gross Profit Growth Q	-99.96%
Net Income	EUR -4M
Net Income Growth Quarters	1%
Net Income Growth Years	2%
Pretax Margin	248.76%
Profit Per Employee	EUR -570,857
Profitable Years	1
ROA	-46.2
ROCE	181.8
ROIC	-101.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	37.53%
Cagr3y	-72.6%
EPS Growth Quarters	1
EPS Growth Years	2
Revenue Growth	-69.64x
Revenue Growth Q	-99.96x
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	EUR 4.5M
Cash	EUR 501,000
Current Assets	EUR 3.9M
Current Liabilities	EUR 7.3M
Debt	EUR 23.5M
Equity	EUR -23.6M
Interest Coverage	-5.28
Liabilities	EUR 28.1M
Long Term Assets	EUR 636,000
Long Term Liabilities	EUR 20.8M
Net Cash	EUR -23M
Net Cash By Market Cap	EUR -1,603
Tangible Book Value	EUR -23.6M
Tangible Book Value Per Share	EUR -0.04
WACC	2.82

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.53
Net Working Capital	EUR -1.2M
Quick ratio	0.5
Working Capital	EUR -3.5M
Working Capital Turnover	EUR 0.65

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-150.43%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	37.5%
200-day SMA	0
3Y total return	-97.94%
50-day SMA	0
50-day SMA vs 200-day SMA	50under200
All Time High	0.35
All Time High Change	-99.37%
All Time High Date	2022-10-27
All Time Low	0
All Time Low Change	83.33%
All Time Low Date	2025-04-24
ATR	0
Beta	-1.6
Beta1y	-0.32
Beta2y	0.09
Ch YTD	-4.35
High	0
High52	0
High52 Date	2025-06-23
High52ch	-31.25%
Low	0
Low52	0
Low52 Date	2025-05-09
Low52ch	57.14%
Ma50ch	-4.35%
Price vs 200-day SMA	-8.33%
RSI	47.08
RSI Monthly	34.25
RSI Weekly	44.16
Sharpe ratio	0.66x
Sortino ratio	1.2
Total Return	-150.43%
Tr YTD	-4.35
Tr1m	-8.33%
Tr1w	-8.33%
Tr3m	-4.35%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -5.1M
Operating margin	215.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	603,174,546%
Net Borrowing	1,029,000
Shares Institutions	0.34%
Shares Out	652,862,279
Shares Qo Q	144.57%
Shares Yo Y	150.43%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	1,930,696.35x
Bv Per Share	-0.04
Ch1m	-8.33
Ch1w	-8.33
Ch1y	37.5
Ch3m	-4.35
Ch3y	-97.94
Ch6m	-4.35
Change	0%
Change From Open	0
Close	0
Days Gap	0
Depreciation Amortization	330,500
Dollar Volume	308
Earnings Date	2026-05-11
EBIT	EUR -5.1M
EBITDA	EUR -4.8M
EPS	EUR -0.01
F Score	3
Financing CF	1,796,000
Fiscal Year End	December
Investing CF	60,000
Is Primary Listing	1
Last Earnings Date	2025-10-27
Last Report Date	2025-06-30
Ma150	0
Ma150ch	-4.35%
Ma20	0
Ma20ch	-4.35%
Net CF	32,000
Next Earnings Date	2026-05-11
Open	0
Ppne	3,000
Price Date	2026-05-08
Relative Volume	0.07x
Revenue	-2,387,000x
Tr6m	-4.35%
Volume	139,979
Z Score	-29.39

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does EBR/BIOS pay a dividend?

Capital-return profile for this ticker.

Performance

EBR/BIOS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns EBR/BIOS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.3%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+150.4%

Negative means the company is buying back shares.

Technical

EBR/BIOS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.1

Neutral momentum band

Price vs 200-day MA

-8.3%

50/200-day relationship not available

Beta (5Y)

-1.60

Less volatile than the market

Sharpe ratio

0.66

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About EBR/BIOS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ebr/BIOS stock rating?

ebr/BIOS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ebr/BIOS analysis?

The full report lives at /stocks/ebr/BIOS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ebr/BIOS?

The latest report frames ebr/BIOS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ebr/BIOS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.